Intelligent Bio Solutions Inc. (INBS) stock
INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3061% below fair value
$1.76−0.17 (-8.81%)
Close on Nov 13, 2026Market cap $5.33MP/E –Yield –
Intelligent Bio Solutions operating margin
Operating margin is operating income as a percentage of revenue.
Intelligent Bio Solutions's operating margin for the twelve months ending Sep 30, 2026 was -272.2%. For fiscal 2026 it was -299.1%, against -349.8% the year before. The highest annual figure on record is -281.4% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -299.1% | +50.7 |
| FY2025 | Jun 30, 2025 | -349.8% | −19.4 |
| FY2024 | Jun 30, 2024 | -330.5% | +671.7 |
| FY2023 | Jun 30, 2023 | -1002.1% | +905.0 |
| FY2022 | Jun 30, 2022 | -1907.1% | −1625.7 |
| FY2021 | Jun 30, 2021 | -281.4% | +1232.3 |
| FY2020 | Jun 30, 2020 | -1513.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | -192.7% | +77.2 |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -346.4% | +21.7 |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -277.8% | +73.5 |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -293.9% | +78.8 |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -269.9% | +42.5 |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -368.1% | +370.1 |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -351.3% | −25.8 |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -372.8% | −155.7 |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -312.4% | −33.6 |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -738.2% | −128.3 |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -325.4% | +1106.2 |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -217.1% | +380.3 |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -278.9% | +112.5 |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -609.9% | +2513.5 |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -1431.6% | −734.1 |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -597.4% | +1352.4 |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -391.4% | −338.3 |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -3123.3% | +6035.4 |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -697.6% | −373.5 |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -1949.8% | −753.7 |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -53.0% | +684.5 |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -9158.7% | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -324.1% | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -1196.2% | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -737.5% | – |
See a number that looks wrong?